Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 362

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 362
---
 • |     | the number and the nature of the conditions to Kineta’s obligation to consummate the Asset Sales and the                              
 risk of non-satisfaction of such conditions as well as the likelihood that the Asset Sales will be consummated on a timely basis; and |

| • |     | the belief that the terms of each of the HCRX Asset Purchase Agreement, the Pacira Asset Purchase Agreement, and                                                                     
 the GigaGen Agreement, including the parties’ representations, warranties and covenants, and the conditions to their respective obligations, are reasonable under the circumstances. |

The Kineta Board of Directors weighed these advantages and opportunities against a number of potentially negative factors in its deliberations concerning the Transactions, including:

| • |     | the risk to Kineta’s financial results in the event that one or both of the Transactions is not consummated, 
 including the risk of Kineta needing to liquidate the company;                                               |

| • |     | the risk that TuHURA’s financial performance may not meet Kineta’s expectations, including any 
 contraction of trading multiples of TuHURA stock during the pendency of the Transaction;       |

| • |     | the impact of external factors on TuHURA’s financial performance and/or trading multiples, including changes 
 in regulation and other macroeconomic and political factors;                                                 |

| • |     | the difficulties and management challenges inherent in completing the Mergers and integrating the business,                                                                                  
 operations and workforce of Kineta and TuHURA and the risk of not capturing all the anticipated synergies and the risk that other anticipated benefits of the Mergers might not be realized; |

| • |     | the amount of time it could take to complete the Mergers, including that completion of the Mergers depends on                                                                                                                               
 factors outside of Kineta’s or TuHURA’s control, and the risk that the pendency of the Mergers for an extended period of time following the announcement of the execution of the Merger Agreement could have an adverse impact on Kineta or 
 TuHURA, including their respective customer, supplier and other business relationships;                                                                                                                                                     |

| • |     | the possible diversion of management attention for an extended period of time during the pendency of the Mergers; |

| • |     | the risk that, despite the retention efforts of Kineta and TuHURA prior to the consummation of the Mergers, 
 Kineta and TuHURA may lose key personnel;                                                                   |